 Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and full year 2019 financial results. Net Revenues for the fourth quarter were 13.7 million, and for the full year 2019, Net Revenues totaled 47.5 million, a 17 increase over the prior year. 